Crossmark

Calprotectin (S100A8/9) as serum biomarker for clinical response in proof-of-concept trials in axial and peripheral spondyloarthritis

Published Online: 2014-08-19

Authors

Turina, Maureen C

Yeremenko, Nataliya

Paramarta, Jacqueline E

De Rycke, Leen

Baeten, Dominique
License Information

Text and Data Mining valid from 2014-08-19

Version of Record valid from 2014-08-19
More Information

Article History

Received: 3 January 2014

Accepted: 25 July 2014

First Online: 19 August 2014

Document is current